Inspire Medical Systems, Inc. (INSP) Gross Margin
- Gross margin · 12 months: Value 86.13%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 86.13% | Gross profit / revenue. Period ending 2026-06-30. $774.11M ÷ $898.74M × 100 ≈ 86.13% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 774.11M USD | Gross Profit |
| Revenue | 898.74M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 124.64M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $774.11M | $898.74M | $124.64M | 86.13% |
| 2026-03-31 | $785.06M | $915.25M | $130.19M | 85.78% |
| 2025-12-31 | $778.76M | $911.98M | $133.22M | 85.39% |
| 2025-09-30 | $749.48M | $882.62M | $133.14M | 84.92% |
| 2025-06-30 | $727.54M | $861.31M | $133.77M | 84.47% |
| 2025-03-31 | $711.17M | $840.11M | $128.94M | 84.65% |
| 2024-12-31 | $679.82M | $802.80M | $122.99M | 84.68% |
| 2024-09-30 | $640.54M | $755.59M | $115.05M | 84.77% |
| 2024-06-30 | $598.67M | $705.71M | $107.04M | 84.83% |
| 2024-03-31 | $559.47M | $660.91M | $101.44M | 84.65% |
| 2023-12-31 | $528.22M | $624.80M | $96.58M | 84.54% |
| 2023-09-30 | $479.52M | $570.19M | $90.67M | 84.10% |
| 2023-06-30 | $440.00M | $526.08M | $86.08M | 83.64% |
| 2023-03-31 | $390.37M | $466.37M | $76.00M | 83.70% |
| 2022-12-31 | $341.74M | $407.86M | $66.11M | 83.79% |
| 2022-09-30 | $293.24M | $348.35M | $55.12M | 84.18% |
| 2022-06-30 | $256.89M | $300.85M | $43.96M | 85.39% |
| 2022-03-31 | $225.12M | $262.42M | $37.30M | 85.79% |
| 2021-12-31 | $200.12M | $233.39M | $33.28M | 85.74% |
| 2021-09-30 | $171.72M | $201.00M | $29.28M | 85.43% |
| 2021-06-30 | $149.29M | $175.16M | $25.87M | 85.23% |
| 2021-03-31 | $114.08M | $134.39M | $20.31M | 84.89% |
| 2020-12-31 | $97.76M | $115.38M | $17.62M | 84.73% |
| 2020-09-30 | $81.58M | $96.28M | (m) | 84.73% |
| 2020-06-30 | $68.35M | $81.30M | (m) | 84.08% |
| 2020-03-31 | $73.06M | $87.15M | (m) | 83.84% |
| 2019-12-31 | $68.41M | $82.05M | (m) | 83.37% |
| 2019-09-30 | $59.11M | $71.70M | (m) | 82.43% |
| 2019-06-30 | $52.29M | $63.90M | (m) | 81.83% |
| 2019-03-31 | $46.19M | $56.80M | (m) | 81.31% |
| 2018-12-31 | $40.54M | $50.59M | (m) | 80.12% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | $22.55M | $28.57M | (m) | 78.93% |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) |
| 2016-12-31 | $12.52M | $16.43M | (m) | 76.23% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |